Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.

Conclusion: Addition of maraviroc to standard c-ART does not improve clinical outcomes of patients initiating therapy for advanced HIV infection.
Primary Funding Source: INSERM-ANRS (French National Agency for Research on AIDS).
PMID: 32040959 [PubMed - as supplied by publisher]

Source: Annals of Internal Medicine - February 10, 2020 Category: Internal Medicine Authors: Lévy Y, Lelièvre JD, Assoumou L, Aznar E, Pulido F, Tambussi G, Crespo M, Meybeck A, Molina JM, Delaugerre C, Izopet J, Peytavin G, Cardon F, Diallo A, Lancar R, Béniguel L, Costagliola D Tags: Ann Intern Med Source Type: research